Cannashield Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Trump’s Rescheduling Push Signals Momentum for Medical Cannabis and CBD
Trump’s push to reschedule cannabis signals growing federal recognition of medical use and opens pathways for expanded research and clearer CBD oversight. While not full legalization, the move reflects momentum rather than restriction.
Congress Pushes for Clarity on Federal Cannabis Enforcement and Future Rescheduling
A U.S. Congresswoman is requesting clarity from the administration on federal cannabis enforcement — especially regarding federal lands and rescheduling. Her inquiry highlights the rising pressure for consistent national policy and the uncertainty operators face as they plan for the future.
Rumors Rise That a Future Trump Administration May Reschedule Cannabis — What It Could Mean for the Industry
Rumors are growing in Washington that a second Trump administration may aggressively pursue federal cannabis rescheduling. If it happens, it would reshape banking, insurance, taxes, and interstate commerce — transforming the entire cannabis industry.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to get you cover?
Call us on (323)905-3396
or growth@cannashield.io
France is moving toward medical cannabis reimbursement, and that shift changes everything from product standards to investment expectations. Here is the operator playbook for a pharma style market.